REVLIMID Label and Medication Guide (February 2015)

Status

Published

on 20 Mar 2015

Year of Creation

2015

Celgene Corporation

Registration Number

TX0008072598

on 20 Mar 2015

The U.S. Copyright record (Registration Number: TX0008072598) dated 20 Mar 2015, pertains to an electronic file (eService) titled "REVLIMID Label and Medication Guide (February 2015)" created in 2015. The copyright holder is Celgene Corporation, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Celgene Corporation.

Celgene Corporation

Application Details

Registration Number

TX0008072598

Registration Date

3/20/2015

Year of Creation

2015

Agency Marc Code

DLC-CO

Record Status

New

Corporate Author

Celgene Corporation

Physical Description

Electronic file (eService)

First Publication Nation

United States

Preexisting Material

text, drawing, graph, compilation

Corporate Authors

Celgene Corporation

Notes

Material Matter Claimed Note: text, revised drawings, revised graph and revised compilation

Previous Registration Note: TX 6305212

Statements

Application Title Statement: REVLIMID Label and Medication Guide (February 2015)

Author Statement: Celgene Corporation employer for hire Domicile: United States Citizenship: United States Authorship: text, revised drawings, revised graph and revised compilation

Notes

Material Matter Claimed Note: text, revised drawings, revised graph and revised compilation

Previous Registration Note: TX 6305212

Statements

Application Title Statement: REVLIMID Label and Medication Guide (February 2015)

Author Statement: Celgene Corporation employer for hire Domicile: United States Citizenship: United States Authorship: text, revised drawings, revised graph and revised compilation

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.